Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2013 1
2014 2
2015 1
2016 1
2018 6
2019 2
2020 4
2021 7
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Medication guide for the perioperative management of oral antineoplastic agents in cancer patients.
Villanueva-Bueno C, Escudero-Vilaplana V, Collado-Borrell R, Giménez-Manzorro Á, Ribed A, Marzal-Alfaro B, Revuelta-Herrero JL, Gonzalez-Haba E, Herranz A, Sanjurjo M. Villanueva-Bueno C, et al. Among authors: gonzalez haba e. Expert Opin Drug Saf. 2022 Jan;21(1):107-119. doi: 10.1080/14740338.2021.1965990. Epub 2021 Aug 12. Expert Opin Drug Saf. 2022. PMID: 34357828 Review.
Predictive biomarkers of response to immune checkpoint inhibitors.
Díaz-Carrasco MS, González-Haba E, García-Soler JI, Espuny-Miró A. Díaz-Carrasco MS, et al. Among authors: gonzalez haba e. Farm Hosp. 2020 Jul 1;44(4):141-148. doi: 10.7399/fh.11328. Farm Hosp. 2020. PMID: 32646345 Review. English.
Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts.
Martin M, Ramos-Medina R, Bernat R, García-Saenz JA, Del Monte-Millan M, Alvarez E, Cebollero M, Moreno F, Gonzalez-Haba E, Bueno O, Romero P, Massarrah T, Echavarria I, Jerez Y, Herrero B, Gonzalez Del Val R, Lobato N, Rincon P, Palomero MI, Marquez-Rodas I, Lizarraga S, Asensio F, Lopez-Tarruella S. Martin M, et al. Among authors: gonzalez haba e. Sci Rep. 2021 Mar 29;11(1):7064. doi: 10.1038/s41598-021-85962-4. Sci Rep. 2021. PMID: 33782404 Free PMC article.
Aggressiveness of end-of-life cancer care: what happens in clinical practice?
García-Martín E, Escudero-Vilaplana V, Fox B, Collado-Borrell R, Marzal-Alfaro B, Sánchez-Isac M, Solano-Garzón ML, González Del Val R, Cano-González JM, Pérez de Lucas N, Bravo-Guillén AI, Valero-Salinas J, González-Haba E, Sanjurjo M, Martín M. García-Martín E, et al. Among authors: gonzalez haba e. Support Care Cancer. 2021 Jun;29(6):3121-3127. doi: 10.1007/s00520-020-05828-9. Epub 2020 Oct 16. Support Care Cancer. 2021. PMID: 33067765
A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application.
García-Sánchez S, Collado-Borrell R, González-Haba E, Revuelta-Herrero JL, Escudero-Vilaplana V, Marzal-Alfaro MB, Sánchez-Fresneda MN, Mur-Mur A, Herranz A, Martín M, Sanjurjo M. García-Sánchez S, et al. Among authors: gonzalez haba e. Front Oncol. 2022 Jun 8;12:889575. doi: 10.3389/fonc.2022.889575. eCollection 2022. Front Oncol. 2022. PMID: 35756684 Free PMC article.
Drug cost avoidance in clinical trials of breast cancer.
Mañes-Sevilla M, Romero-Jiménez R, Herranz-Alonso A, Sánchez-Fresneda M, Gonzalez-Haba E, Collado-Borrel R, Benedi-González J, Sanjurjo-Sáez M. Mañes-Sevilla M, et al. Among authors: gonzalez haba e. J Oncol Pharm Pract. 2019 Jul;25(5):1099-1104. doi: 10.1177/1078155218775193. Epub 2018 May 23. J Oncol Pharm Pract. 2019. PMID: 29792122
Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility.
Gómez-Centurión I, Oarbeascoa G, García MC, López Fresneña MC, Martínez Carreño MJ, Escudero Vilaplana V, González-Haba E, Bailén R, Dorado N, Juárez LM, Rodríguez Macías G, Font López P, Encinas C, Bastos-Oreiro M, Anguita J, Sanjurjo M, Díez-Martin JL, Kwon M. Gómez-Centurión I, et al. Among authors: gonzalez haba e. Int J Hematol. 2022 Jan;115(1):61-68. doi: 10.1007/s12185-021-03219-2. Epub 2021 Sep 22. Int J Hematol. 2022. PMID: 34553338 Free PMC article.
A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital.
Villanueva-Bueno C, Collado-Borrell R, Escudero-Vilaplana V, Revuelta-Herrero JL, Marzal-Alfaro MB, González-Haba E, Arranz-Arija JÁ, Osorio S, Herranz-Alonso A, Sanjurjo-Saez M. Villanueva-Bueno C, et al. Among authors: gonzalez haba e. Front Public Health. 2022 Nov 4;10:978783. doi: 10.3389/fpubh.2022.978783. eCollection 2022. Front Public Health. 2022. PMID: 36407983 Free PMC article.
Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents.
Escudero-Vilaplana V, Collado-Borrell R, Gómez Martínez-Sagrera P, Villanueva-Bueno C, Revuelta-Herrero JL, Gonzalez-Haba E, Hoyo-Muñoz Á, Jerez Gilarranz Y, Marzal-Alfaro B, Herranz A, Martin M, Sanjurjo M. Escudero-Vilaplana V, et al. Among authors: gonzalez haba e. J Cancer Res Clin Oncol. 2023 Jul;149(7):2855-2882. doi: 10.1007/s00432-022-04172-1. Epub 2022 Jul 6. J Cancer Res Clin Oncol. 2023. PMID: 35790560
Assessment of diarrhea as side effect of oral targeted antineoplastic agents in clinical practice.
Escudero-Vilaplana V, Collado-Borrell R, Del Monte-Millán M, Hoyo-Muñoz A, Gómez Martínez-Sagrera P, Revuelta-Herrero JL, Marzal-Alfaro B, Gonzalez-Haba E, López-Tarruella Cobo S, Jerez Gilarranz Y, Herranz A, Sanjurjo M, Martin M. Escudero-Vilaplana V, et al. Among authors: gonzalez haba e. Support Care Cancer. 2021 Aug;29(8):4673-4681. doi: 10.1007/s00520-021-06016-z. Epub 2021 Jan 28. Support Care Cancer. 2021. PMID: 33506273
26 results